Literature DB >> 27611363

Centipede venoms as a source of drug leads.

Eivind A B Undheim1,2, Ronald A Jenner3, Glenn F King1.   

Abstract

INTRODUCTION: Centipedes are one of the oldest and most successful lineages of venomous terrestrial predators. Despite their use for centuries in traditional medicine, centipede venoms remain poorly studied. However, recent work indicates that centipede venoms are highly complex chemical arsenals that are rich in disulfide-constrained peptides that have novel pharmacology and three-dimensional structure. Areas covered: This review summarizes what is currently known about centipede venom proteins, with a focus on disulfide-rich peptides that have novel or unexpected pharmacology that might be useful from a therapeutic perspective. The authors also highlight the remarkable diversity of constrained three-dimensional peptide scaffolds present in these venoms that might be useful for bioengineering of drug leads. Expert opinion: Like most arthropod predators, centipede venoms are rich in peptides that target neuronal ion channels and receptors, but it is also becoming increasingly apparent that many of these peptides have novel or unexpected pharmacological properties with potential applications in drug discovery and development.

Entities:  

Keywords:  Therapeutic; bioengineering; biologic; centipede venom; drug discovery; ion channel; peptide drug; venom peptide; venomics

Mesh:

Substances:

Year:  2016        PMID: 27611363     DOI: 10.1080/17460441.2016.1235155

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  14 in total

1.  Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.

Authors:  Alexandria S Senetra; Matthew R Necelis; Gregory A Caputo
Journal:  Pept Sci (Hoboken)       Date:  2020-03-31

2.  Proteotranscriptomic Analysis and Discovery of the Profile and Diversity of Toxin-like Proteins in Centipede.

Authors:  Feng Zhao; Xinqiang Lan; Tao Li; Yang Xiang; Fang Zhao; Yun Zhang; Wen-Hui Lee
Journal:  Mol Cell Proteomics       Date:  2018-01-16       Impact factor: 5.911

Review 3.  Neuropeptide signalling systems - An underexplored target for venom drug discovery.

Authors:  Helen C Mendel; Quentin Kaas; Markus Muttenthaler
Journal:  Biochem Pharmacol       Date:  2020-06-30       Impact factor: 5.858

4.  True Lies: Using Proteomics to Assess the Accuracy of Transcriptome-Based Venomics in Centipedes Uncovers False Positives and Reveals Startling Intraspecific Variation in Scolopendra Subspinipes.

Authors:  Jennifer J Smith; Eivind A B Undheim
Journal:  Toxins (Basel)       Date:  2018-02-28       Impact factor: 4.546

5.  Why be red listed? Threatened Myriapoda species in Brazil with implications for their conservation.

Authors:  Manoela Karam-Gemael; Thiago Junqueira Izzo; Amazonas Chagas
Journal:  Zookeys       Date:  2018-03-07       Impact factor: 1.546

Review 6.  Animal Toxins Providing Insights into TRPV1 Activation Mechanism.

Authors:  Matan Geron; Adina Hazan; Avi Priel
Journal:  Toxins (Basel)       Date:  2017-10-16       Impact factor: 4.546

Review 7.  The Role of Toxins in the Pursuit for Novel Analgesics.

Authors:  Yossi Maatuf; Matan Geron; Avi Priel
Journal:  Toxins (Basel)       Date:  2019-02-23       Impact factor: 4.546

8.  Centipede Venom Peptides Acting on Ion Channels.

Authors:  YanYan Chu; PeiJu Qiu; RiLei Yu
Journal:  Toxins (Basel)       Date:  2020-04-05       Impact factor: 4.546

9.  Mitochondrial activity disruption and local muscle damage induced in mice by Scolopendra polymorpha venom.

Authors:  Judith Tabullo De Robles; Francisca Fernández Valverde; Lucero Valladares Cisneros; Juana Hernández Villeda; Ayixon Sánchez-Reyes; María Del Carmen Gutiérrez
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-05-29

Review 10.  Marine Toxins and Nociception: Potential Therapeutic Use in the Treatment of Visceral Pain Associated with Gastrointestinal Disorders.

Authors:  Andreina Baj; Michela Bistoletti; Annalisa Bosi; Elisabetta Moro; Cristina Giaroni; Francesca Crema
Journal:  Toxins (Basel)       Date:  2019-07-31       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.